Search research articles
Contact Us
Filters
Showing results (321-330 of 500) with videos related to
Page
of 50
Sort By:
Leukemia
|
July 17, 1998
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison
W Kern, C Aul, G Maschmeyer, et al.
Leukemia
|
August 1, 1994
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)
C Fonatsch, H Gudat, E Lengfelder, et al.
Leukemia
|
September 1, 1994
Characterization of the monocyte-specific esterase (MSE) gene
C C Uphoff, Z B Hu, S M Gignac, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
May 23, 2019
Evaluation of the Suitability of Miniature Pigs as an Animal Model of Juvenile Osteochondritis Dissecans
Ferenc Tóth, Casey P Johnson, Benigno Mills, et al.
Biorxiv : the Preprint Server for Biology
|
October 2, 2023
Species-wide quantitative transcriptomes and proteomes reveal distinct genetic control of gene expression variation in yeast
E Teyssonnière, P Trébulle, J Muenzner, et al.
Blood
|
January 11, 2000
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report
A Reiter, M Schrappe, W D Ludwig, et al.
Haematology and Blood Transfusion
|
January 1, 1990
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM)
W Hiddemann, H C Aul, G Maschmeyer, et al.
Pharmacopsychiatry
|
March 31, 2004
Blood dyscrasias induced by psychotropic drugs
S Stübner, R Grohmann, R Engel, et al.
Klinische Padiatrie
|
July 1, 1994
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group]
A Reiter, M Tiemann, W D Ludwig, et al.
Haematologica
|
February 27, 2001
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping
C Wuchter, R Ratei, G Spahn, et al.
Page
of 50
Search research articles
Search
Showing results (321-330 of 500) with videos related to
Sort By:
Page
of 50
Leukemia
|
July 17, 1998
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison
W Kern, C Aul, G Maschmeyer, et al.
Leukemia
|
August 1, 1994
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)
C Fonatsch, H Gudat, E Lengfelder, et al.
Leukemia
|
September 1, 1994
Characterization of the monocyte-specific esterase (MSE) gene
C C Uphoff, Z B Hu, S M Gignac, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
May 23, 2019
Evaluation of the Suitability of Miniature Pigs as an Animal Model of Juvenile Osteochondritis Dissecans
Ferenc Tóth, Casey P Johnson, Benigno Mills, et al.
Biorxiv : the Preprint Server for Biology
|
October 2, 2023
Species-wide quantitative transcriptomes and proteomes reveal distinct genetic control of gene expression variation in yeast
E Teyssonnière, P Trébulle, J Muenzner, et al.
Blood
|
January 11, 2000
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report
A Reiter, M Schrappe, W D Ludwig, et al.
Haematology and Blood Transfusion
|
January 1, 1990
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM)
W Hiddemann, H C Aul, G Maschmeyer, et al.
Pharmacopsychiatry
|
March 31, 2004
Blood dyscrasias induced by psychotropic drugs
S Stübner, R Grohmann, R Engel, et al.
Klinische Padiatrie
|
July 1, 1994
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group]
A Reiter, M Tiemann, W D Ludwig, et al.
Haematologica
|
February 27, 2001
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping
C Wuchter, R Ratei, G Spahn, et al.
Page
of 50